Highlights from this issue
‘To CT or not to CT? That is the question’
Pneumococcal capsular serotypes and lung infection
Mesenchymal stem cell therapy in acute lung injury
uPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium
Lebrikizumab may benefit a subset of patients with asthma
The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation
Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat
Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
Progression of early structural lung disease in young children with cystic fibrosis assessed using CT
Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells
Positive pre-resection pleural lavage cytology is associated with increased risk of lung cancer recurrence in patients undergoing surgical resection
Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia
Proposal for a systematic analysis of polygraphy or polysomnography for identifying and scoring abnormal events occurring during non-invasive ventilation
Mechanisms of neutrophil transmigration across the vascular endothelium in COPD
Pragmatic trials
Authors' response
Granulomatosis with polyangitis (Wegener's)
All that wheezes is not asthma
Mesenchymal stem cells